Latest filing published 05 Mar 2025 for Viatris Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -11.4%Entry US$11.76 · Close at T+365 US$10.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Harry Korman: trading record in brief
Filings by Harry Korman span 3 companies, the busiest being Mylan Laboratories Inc, Viatris Inc and Mylan II B.V. We count 80 filings; the first trade dates from 15 February 2006 and the latest from 4 March 2025.
Market trades split into 10 purchases (€52k) and 12 sales (€8.4M). On balance, insiders were net sellers of €8.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 17 share grants and 40 option exercises.
In size, the median ticket on the buying side is €3,186.
On 5 March 2025 came the latest disclosure, an option exercise in Viatris Inc. The last purchase on record was published on 25 October 2024, which is 744 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Harry Korman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 773 shares0Common StockSEC:0000950170-25-034018:1
- 18,204 shares0Common StockSEC:0000950170-25-034018:0
- 144.73 shares@ US$15.39Common StockSEC:0000950170-24-117437:4Canonical exit: 14 Sept 2021 (T+90)
- 19 shares@ US$9.01100.0% of flowCommon StockSEC:0000950170-24-117437:9Canonical exit: 24 Jan 2024 (T+90)
- 837 shares@ US$16.99Common StockSEC:0000950170-24-117437:1Canonical exit: 15 Apr 2021 (T+90)
- 713 shares@ US$14.97Common StockSEC:0000950170-24-117437:2Canonical exit: 26 May 2021 (T+90)
- 349 shares@ US$13.94Common StockSEC:0000950170-24-117437:3Canonical exit: 7 Jun 2021 (T+90)
- 162.44 shares@ US$13.81Common StockSEC:0000950170-24-117437:5Canonical exit: 15 Dec 2021 (T+90)
- 176.17 shares@ US$12.84Common StockSEC:0000950170-24-117437:6Canonical exit: 16 Mar 2022 (T+90)
- 1,150 shares@ US$10.08Common StockSEC:0000950170-24-117437:7Canonical exit: 2 Jun 2022 (T+90)
- 238.76 shares@ US$10.42Common StockSEC:0000950170-24-117437:8Canonical exit: 14 Jun 2022 (T+90)
- 613 shares@ US$17.147100.0% of flowCommon StockSEC:0000950170-24-117437:0Canonical exit: 11 Mar 2021 (T+90)
- 885 shares0Common StockSEC:0000950170-24-026670:1
- 17,970 shares0Common StockSEC:0000950170-24-026670:0
- 705 shares0Common StockSEC:0000899243-23-007224:1
- 19,608 shares0Common StockSEC:0000899243-23-007224:0
- 166 shares0Common StockSEC:0000899243-22-011981:0
- 335 shares0Common StockSEC:0000899243-22-009554:1
- 13,996 shares0Common StockSEC:0000899243-22-009554:0
- 9,440 shares0Common StockSEC:0000899243-21-009928:0
- 26,515 sharesOrdinary SharesSEC:0000899243-20-031501:0
- 26,515 sharesCommon StockSEC:0000899243-20-031554:0
- 2,430 shares@ US$17.48100.0% of flowOrdinary SharesSEC:0000899243-20-007028:1
- 6,011 shares0Ordinary SharesSEC:0000899243-20-007028:0
- 4,566 shares0Ordinary SharesSEC:0000899243-19-006226:0
25 of 80 declarations
